CD8A and neoplasm: A high proportion of splenic CD11c+CD8+DCs was detected in a mouse model treated with an engineered adenovirus, moreover, tumor-infiltrating plasmacytoid DCs displayed a mature phenotype with the ability to prime tumor-specific cytotoxic T cell responses (24).